• English
    • español
    • português (Brasil)
  • português (Brasil) 
    • English
    • español
    • português (Brasil)
  • Entrar
Ver item 
  •   COVID-19
  • Resources in English
  • Technical documents and research evidence on COVID-19
  • Ver item
  •   COVID-19
  • Resources in English
  • Technical documents and research evidence on COVID-19
  • Ver item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Zika virus infections in Nigeria: virological and seroepidemiological investigations in Oyo State

 
Thumbnail
Data
2014
Autor
Fagbami, A. H.
Metadata
Mostrar registro completo
Resumo
A study of Zika virus infections was carried out in four communities in Oyo State, Nigeria. Virus isolation studies between 1971 and 1975 yielded two virus isolations from human cases of mild febrile illness. Haemagglutination-inhibition tests revealed a high prevalence of antibodies to Zika and three other flaviviruses used. The percentages of positive sera were as follows: Zika (31%), Yellow fever (50%), West Nile (46%), and Wesselsbron (59%). Neutralization tests showed that 40% of Nigerians had Zika virus neutralizing antibody. Fifty per cent of zika virus immune persons had neutralizing antibody to Zika alone or to Zika and one other flavivirus. A total of 121 sera had antibody to Zika virus; of these 48 (40%) also showed antibody to two other flaviviruses, and 12 (10%) had antibodies to three or more other viruses. The percentage of neutralizing antibodies to other flaviviruses in Zika virus immune sera was 81% to Dengue type 1, 58% to Yellow fever, 7% to Wesselsbron, 6% to West Nile and 3% to Uganda S.
URI
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2129900/
Collections
  • Technical documents and research evidence on COVID-19

Navegar

Todo o repositórioComunidades e ColeçõesPor data do documentoAutoresTítulosCategoriaAssuntosEsta coleçãoPor data do documentoAutoresTítulosCategoriaAssuntos

Minha conta

EntrarCadastro

Organização Pan-Americana da Saúde
Organização Mundial da Saúde. Escritório Regional para as Américas.
525 Twenty-third Street, N.W., Washington, D.C. 20037, Estados Unidos

Notas importantes sobre el contenido (Disclaimer)

Links

  • OPAS Doença por Coronavírus ‎‎(COVID-19)‎
  • OPAS/BIREME Vitrines do Conhecimento COVID-19

  • Biblioteca Digital da OPAS (IRIS PAHO)
  • Biblioteca Virtual em Saúde (BVS)
  • Global Index Medicus (GIM)